Government to Revise Drug Regulations to Support Drug Development
The government is set to revise drug regulations to support the development of new drugs through drug discovery and clinical trials. The aim is to establish a system that can support the research and development of new drugs from inception to practical application. This move comes as part of the government’s efforts to address the issue of “drug lag” and expedite the development of new medications.
The proposed support measures include the establishment of clinical trial facilities and the revision of drug regulations to facilitate the process of drug development. The government’s focus is on promoting drug discovery and innovation in the pharmaceutical industry to ensure the timely availability of safe and effective medications for patients.
The new regulations are expected to streamline the drug development process and reduce the time it takes for new drugs to reach the market. By providing support for drug discovery and clinical trials, the government aims to foster innovation in the pharmaceutical industry and improve access to cutting-edge medications for patients in need.
This initiative is part of the government’s broader efforts to promote innovation in the healthcare sector and ensure that patients have access to the latest and most effective treatments. The revision of drug regulations is expected to have a significant impact on the pharmaceutical industry and accelerate the development of new drugs for various medical conditions.